Assembly Biosciences, Inc. (ASMB) DCF Valuation

Assembly Biosciences, Inc. (ASMB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Assembly Biosciences, Inc. (ASMB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline Assembly Biosciences, Inc. (ASMB) valuation with this versatile DCF Calculator! With real Assembly Biosciences, Inc. (ASMB) financials and adjustable forecast inputs, you can explore various scenarios and determine Assembly Biosciences, Inc. (ASMB) fair value in just minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 16.0 79.1 6.3 .0 7.2 5.5 4.2 3.3 2.5 1.9
Revenue Growth, % 0 395.55 -92.09 -100 0 -23.02 -23.02 -23.02 -23.02 -23.02
EBITDA -102.7 -64.8 -91.9 -92.6 -64.2 -3.1 -2.4 -1.8 -1.4 -1.1
EBITDA, % -643.44 -81.89 -1469.97 100 -896.22 -56.38 -56.38 -56.38 -56.38 -56.38
Depreciation .5 .7 .5 .5 .5 1.3 1.0 .8 .6 .5
Depreciation, % 3.09 0.87352 7.45 100 6.28 23.54 23.54 23.54 23.54 23.54
EBIT -103.2 -65.5 -92.4 -93.1 -64.6 -3.1 -2.4 -1.8 -1.4 -1.1
EBIT, % -646.54 -82.76 -1477.42 100 -902.5 -56.55 -56.55 -56.55 -56.55 -56.55
Total Cash 274.0 216.4 146.6 91.6 130.2 5.5 4.2 3.3 2.5 1.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 3.4 1.2 .3 .9 .0
Account Receivables, % 21.14 1.55 5.37 100 0.60031
Inventories .0 .0 .0 .0 -3.2 .6 .5 .4 .3 .2
Inventories, % 0 0 0.000015989767 100 -44.63 11.07 11.07 11.07 11.07 11.07
Accounts Payable 1.7 4.6 2.7 2.5 .5 1.8 1.4 1.1 .8 .6
Accounts Payable, % 10.84 5.81 42.52 100 6.44 33.12 33.12 33.12 33.12 33.12
Capital Expenditure -1.6 -2.2 -3.1 -.1 -.3 -.7 -.6 -.4 -.3 -.3
Capital Expenditure, % -9.74 -2.81 -49.5 100 -3.56 -13.12 -13.12 -13.12 -13.12 -13.12
Tax Rate, % -0.05392597 -0.05392597 -0.05392597 -0.05392597 -0.05392597 -0.05392597 -0.05392597 -0.05392597 -0.05392597 -0.05392597
EBITAT -102.4 -62.7 -90.6 -92.1 -64.7 -3.1 -2.4 -1.8 -1.4 -1.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -105.1 -59.2 -94.3 -92.4 -62.4 -6.3 -1.9 -1.4 -1.1 -.9
WACC, % 7.13 7.13 7.13 7.13 7.13 7.13 7.13 7.13 7.13 7.13
PV UFCF
SUM PV UFCF -10.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1
Terminal Value -17
Present Terminal Value -12
Enterprise Value -22
Net Debt -17
Equity Value -5
Diluted Shares Outstanding, MM 5
Equity Value Per Share -1.02

What You Will Get

  • Pre-Filled Financial Model: Assembly Biosciences' actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers specific to ASMB.
  • Instant Calculations: Automatic updates ensure you see results as you make changes in real-time.
  • Investor-Ready Template: A polished Excel file designed for professional-grade valuation of Assembly Biosciences.
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts on ASMB.

Key Features

  • Comprehensive Data: Assembly Biosciences' historical financial statements and detailed projections.
  • Customizable Parameters: Adjust inputs such as WACC, tax rates, revenue growth, and EBITDA margins.
  • Real-Time Insights: View Assembly Biosciences' intrinsic value update instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based ASMB DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically recalculates Assembly Biosciences’ intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial analysis.

Why Choose This Calculator for Assembly Biosciences, Inc. (ASMB)?

  • Accuracy: Utilizes real Assembly Biosciences financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and test various input parameters.
  • Time-Saving: Eliminate the need to create a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for investment analysis in Assembly Biosciences, Inc. (ASMB).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Assembly Biosciences, Inc. (ASMB).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotechnology firms like Assembly Biosciences, Inc. (ASMB) are valued in the market.

What the Template Contains

  • Historical Data: Includes Assembly Biosciences, Inc.'s (ASMB) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Assembly Biosciences, Inc.'s (ASMB) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Assembly Biosciences, Inc.'s (ASMB) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.